Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Associate Scientist, Analytical Development

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Feb 7, 2023

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

As a Senior Associate Scientist, you will join our analytical development team within the Technical Operations group and embrace the opportunity to transform incredible sciences and technologies into powerful cures. In addition, you will be evaluating, implementing, and developing analytical methods to support internal and external manufacturing processes.

Primary responsibilities also include:

  • Support the development of new methods and executing analytical methods to support ongoing Oligonucleotide needs using instruments including but not limited to Ion Pair RP-HPLC, IEX-HPLC, and Mass Spectrometry.

  • Participate in support of analytical activities at CMOs and CTOs related to analytics, including GMP method qualification and validation, troubleshooting, optimization, review, and reporting

About You:

Are you interested in the characterization of oligonucleotides? Do you enjoy troubleshooting experiments with unexpected results? Are you interested in developing and writing analytical methods that can withstand a GMP setting? If you say yes, we encourage you to apply! Other qualifications and desired skills include:

  • Bachelor’s degree in Biochemistry, Chemistry, Biology, or related area with 8+ years of hands-on industrial experience, or Master’s degree with a minimum of five years of research experience

  • Proficient in HPLC techniques, including method development and troubleshooting experience is a must. Prior experience with LC/MS is a plus.

  • Organized, detail-oriented, and demonstrated independent thinker who continuously seeks innovative solutions.

  • Excellent verbal and written communication, teamwork, and strong problem-solving skills

Meet your future team:

The Analytical Development team is a group of energetic, brilliant, fun, and motivated individuals. We work on different modalities as one team to achieve our goals. We are a growing family. While much of the day-to-day operations are on-site and require wet-lab work, our team fosters an environment for career growth as scientists in the biopharmaceutical industry. Your future hiring manager is interested in developing the career of young scientists and building technical expertise. You will work closely with your future hiring manager in the lab to develop innovative methods to characterize a wide range of biological molecules.

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert